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Osmotic control of prolactin release and its effects on renal water
excretion in man. Prolactin appears to play a role in os-
moregulation of fishes and birds, and a possible contribution of
this hormone to the regulation of salt and water excretion in
mammals has been suggested as well. The present studies were
undertaken to investigate the role of osmotic pressure on the
secretion of prolactin and the effect of the hormone on renal water
excretion in man. The iv. administration of synthetic thyrotropin-
releasing hormone (TRH) (7 ag/kg) to five subjects undergoing a
maximal sustained water diuresis increased serum prolactin to
supraphysiologic levels in all as mean concentration rose from 30.2
+ 2.9 to 60.2 5.0 ng/ml (P < 0.005). This increase was not
associated with either significant alterations in renal hemodynam-
ics or sodium excretion and water excretion. The osmoregulation
of prolactin release was then investigated by the oral administra-
tion of 20 mI/kg of water to seven subjects in II studies. While the
water load decreased serum osmolality from 293 1.7 to 285 1.5
mOsm/kg H20 (P < 0.001), there was no significant change in
prolactin level, 28 + 1.8 to 30 2.4 ng/ml. Serum hypertonicity
was achieved in six subjects with the infusion of 5% NaCI which
increased serum osmolality from 287 1.8 to 298 + 1.4 mOsm/kg
(P <0.001). While the hypertonic state caused a marked antidiure-
sis as urinary osmolality rose from 62 + 5.9 to 480 + 48 mOsm/kg
(P < 0.001), the concentration of prolactin remained unchanged at
28 ng/ml. We conclude that supraphysiologic levels of prolactin
have no antidiuretic properties in a vasopressin-free state and that
acute alterations in serum tonicity within the range observed do
not affect the release of prolactin in man.
Contrôle osmotique de Ia liberation de prolactine et effet de Ia
prolactine sur l'excrétion rénale d'eau chez l'homme. La prolactine
parait jouer un role dans l'osmoregulation des poissons et des
oiseaux et, de Ia mêmc facon, une contribution de cette hormone a
Ia regulation de l'excrétion d'eau et de sd chez les mammifères a
été suggérée. Ce travail a été entrepris pour étudier Ic role de
Ia pression osmotique sur Ia sécrétion de prolactine et l'effet
de l'hormone sur l'excrétion rénale d'eau chez I'homme.
L'administration intra-veineuse de thyrotropin releasing horome
(Trh) de synthèse (7 tg/kg) a cinq sujets soumis a une diurèse
aqueuse maimale a déterminé l'augmentation de Ia concentration
sérique de prolactine a des niveaux supra-physiologiques (de 30,2
+ 2,9 a 60,2 5,0 ng/mI, P < 0,005). Cette augmentation n'a été
associée ni a une modification significative de I'hemodynamique
rénale, ni a une modification significative de l'excrétion d'eau et de
sodium. La regulation par l'osmolalité de Ia liberation de pro-
lactine a été explorée par l'administration d'eau (20 mI/kg) a sept
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sujets au cours de II etudes. Alors que Ia charge en eau fait baisser
losmolalité plasmatique de 293 + 1,7 a 285 + 1,5 mOsm/kg H20
(P < 0,00!) il n'y a pas de modification significative de Ia concen-
tration de prolactine (28 + 1,8 a 30 + 2,4 ng/ml). Une hypertoni-
cite a etC réalisée chez six sujets par l'administration de NaCI 5%,
ce qui a fait augmenter l'osmolalité de 287 + 1,8 a 298 + 1,4
mOsm/kg (P < 0,00!). Alors que I'hypertonicitC determine une
antidiurCse importante traduite par une augmentation de
!'osmolalité urinaire de 62 + 5,9 a 480 48 mOsm/kg (P < 0,001),
Ia concentration de prolactine est inchangCe (28 ng/m!). Nous
concluons que des concentrations supra-physiologiques de pro-
lactine n'ont pas de propriétés antidiurétiques et que des modifi-
cations aiguës de l'osmolalité plasmatique, dans l'intervalle des
valeurs observées, ne modiflent pas Ia liberation de prolactine chez
I'homme.
The anterior pituitary hormone prolactin, which
plays a pivotal role in the physiology of lactation,
seems to be an osmoregulatory hormone in fishes [I]
and birds [2]. Findings of studies in which the per-
fused cat kidney [3], the unanesthetized rat [4], the
rat with congenital pituitary diabetes insipidus [5] as
well as man [6] appear to respond to the administra-
tion of prolactin with a decrease in cation or water
excretion or both suggest a role for the hormone in
the control of fluid balance in mammals as well. That
such an action of prolactin may be of physiologic
importance, at least in the rat, is further supported by
the observed increase in sodium, potassium and wa-
ter excretion that follows the chronic administration
of 2 bromo-alpha-ergokryptine [7], a known inhib-
itor of prolactin secretion [8]. The effects of increased
concentrations of endogenous prolactin on the renal
function of man have so far not been fully studied
and, although suggested by the above studies, a role
of the hormone in the maintenance of water balance
remains also to be elucidated. The present study was
therefore undertaken to determine 1) what changes in
renal hemodynamics, sodium and water excretion ac-
company an increase in the blood concentration of
endogenous prolactin, and 2) whether there is an
osmolar control of prolactin release in adult man.
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Methods
The study used only healthy male volunteers be-
tween the ages of 25 and 50 yr. The employed pro-
tocols were approved by the Human Experimen-
tation Committee and all volunteers were fully
informed of the nature of the study. All subjects
fasted and refrained from smoking from midnight of
the day of the study. Experiments were started ap-
proximately at 8:00 AM. The effect of prolactin on
various indexes of renal function in man was studied
in five subjects. These received a priming dose of 50 g
of inulin and 2 g of para-aminohippurate (PAH)
followed by a sustaining solution of these drugs dis-
solved in normal saline and administered at I mi/mm
by a roller pump (Holter Co., King of Prussia, PA).
A water diuresis was established by the oral intake of
20 mI/kg of water over 30 mm. Urine was collected
every ten minutes and losses were replaced orally.
When the water diuresis was established as evidenced
by no further drop in urinary osmolality or an in-
crease in urine flow over three collections, synthetic
thyrotopin-releasing hormone (TRH), 7 ag/kg (Ab-
bott Co., North Chicago, IL), a reliable stimulus to
endogenous prolactin secretion, was given rapidly
intravenously [9]. The activity of the TRH was con-
firmed by measuring concentrations of TSH (Pha-
debas TSH test, Pharmacia, Sweden) before and after
its administration to five of the subjects. TSH rose in
each as the mean levels increased from 2.9 0.4 to
21.7 2,4 U of TSH/ml of serum (P <0.001). After
TRH administration, and allowing for a ten-minute
equilibration period, urine collections were continued
for one hour. Venous blood was drawn without stasis
in the fasting state, at the height of the water diuresis
just prior to and 20, 40 and 60 mm after the adminis-
tration of TRH. Blood and urine specimens were
analyzed for sodium (Flame photometer, Instrumen-
tation Laboratories, Boston, MA), osmolality (Fiske
Associates, Uxbridge, MA), inulin [10] and PAH
[II]. In addition, blood concentrations of prolactin
were measured by radioimmunoassay. Human pro-
lactin (HPRL), composed of isohormones B and C,
isolated from amniotic fluid [12], was used for radio-
iodination and also served as a reference hormone. In
contrast to the available pituitary HPRL, this prepa-
ration has been found to be stable for one year if kept
frozen at —70°C, and there has been no difficulty in
obtaining a good tracer with it. Rabbit anti-human
prolactin was kindly supplied by the Public Health
Service, National Institute of Arthritis, Metabolic,
and Digestive Diseases, Bethesda, MD; goat anti-
rabbit immunoglobulin (M iles-Yeda, Rehovot, Is-
rael) served as the second antibody for the double
antibody radioimmunoassay. lodination with 1251was
performed by the method of Greenwood, Hunter and
Glover [13]. Separation of the labelled intact protein
from damaged molecules and free iodine was carried
out in a 22 x 0.9 cm column containing Sephadex G-
75 coated with 0.5 ml of 30% bovine serum albumin
(BSA) in phospho saline buffer (PSB)(0.IM, pH 7.6),
and the solution was then washed with PSB. The
immunoreactive labelled prolactin was found in the
second peak, while damaged molecules appeared in
the first peak. The specific activity of the labelled
prolactin ranged from 80 to 150 mCi/mg. The
method was found to be specific for HPRL. Neither
human placental lactogen nor human growth hor-
mone was detectable in the assay system. Moreover,
large doses of human follicle-stimulating hormone
and thyroid-stimulating hormone were completely in-
effective in inhibiting the reaction of labelled HPRL
with anti-HPRL, To test whether a serum com-
ponent, other than prolactin, interfered with the in-
hibition curve of the radioimmunoassay, a "serum
standard curve" was also performed; serum with a
high prolactin concentration (40 mg/0.l ml) pooled
from women in late pregnancy and hyperprolacti-
nemic patients served as the highest prolactin concen-
tration point on the curve. Also, a standard curve of
human pituitary prolactin, obtained from the Na-
tional Institutes of Health, was constructed. Parallel
curves to that of the amniotic fluid HPRL were ob-
tained. The serum with the high prolactin concentra-
tion and serum with 1.8 ng/0.1 ml of prolactin,
pooled from normal male and female subjects, were
used as the "laboratory internal reference" and were
run with each assay. The interassay percent varia-
tions were found not to exceed 8%. In this laboratory,
the concentration of serum prolactin measured in
normal adults of either sex at various times of the day
is between 4 and 34 ng/ml.
The effect of changes of serum tonicity on prolactin
release was studied in six subjects whose serum was
rendered hypertonic by a modification of the method
of Moses, Streeten and Streeten [14]. Thus, following
the establishment of a water diuresis, an infusion of
5% NaCI at 0.05 mI/kg/mm was begun and contin-
ued for two hours. Upon cessation of the infusion,
TRH was administered as described above. Urine
was collected every 15 mm and blood specimens were
drawn in the fasting state, at the height of the water
diuresis, at one and two hours after the hypertonic
NaCI infusion was begun and 20, 40 and 60 mm after
TRH administration. Blood and urine specimens
were analyzed for sodium and osmolality and blood
specimens for prolactin as described above.
The effect of TRH infusion on prolactin release in
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Table 1. Effect of thyroid-releasing hormone (TRU) on serum prolactin levels in various states of hydration (ng/ml)a
Overnight dehydration Water-loaded Hypertonic volume expansion
Before After Subject Before AfterSubject Before After Subject
No. TRH TRH No. TRH TRH No. TRH TRH
14 28 I 27 69 I 26 58
2 23 38 2 20 45 2 30 54
3 20 48 6 34 62 6 34 60
4 22 52 7 36 72 7 30 62
5 35 48 8 34 53 9 25 40
10 21 47
Mean 22.8 42.8 30.2 60.2 27.7 53.5
SESI 3.4 4.3 2.9 5.0 1.9 3.5
Pvalue <0.01 <0.005 <0.001
a Prolactin concentrations are 20 mm after TRH administration.
the hydropenic state was studied in five subjects fol- Effect of prolactin on renal hemodynamics, sodium
lowing overnight dehydration. Prolactin concentra- and water excretion. As noted in the middle panel of
tions were determined 20 mm before, just prior to Table 1, water loading by no means altered the pro-
and 20, 40 and 60 mm after TRH administration. lactin stimulatory effect of TRH. Thus, the level of
Student's t test was employed for statistical analysis. prolactin rose well above the physiologic range in all
A P value greater than 0.05 was considered not signif- five subjects as mean concentrations increased from
icant. 30,2 2.9 to 60.2 + 5.0 ng/ml (P < 0.005). As shown
Results
in Table 2, this increase in serum prolactin levels was
associated with no alteration in water excretion in
Effect of TRH on prolactin release in hydropenic any of these subjects as both free water clearance and
man. The i.v. administration of 7 tg/kg of TRH urinary osmolality were unchanged. Likewise, no sta-
caused no changes in systemic pressure, which was tistically significant change in either inulin clearance,
measured in approximately 50% of the subjects. Most PAH clearance or the rate of sodium excretion was
of them did report a sensation of nausea which sub- observed in association with the increased concentra-
sided within minutes. The ability of the tripeptide to tions of prolactin.
cause a consistent and significant increase in serum Effect of alterations in serum tonicity on prolactin
prolactin when given after an overnight fast is shown release. A decrease in serum tonicity was achieved by
in Table I, left panel. The magnitude of increase is an oral water load 11 times in seven subjects (Table
similar to that reported previously [9] as mean con- 3). The load caused the serum sodium concentration
centration rose from 22.8 + 3.4 to 42.8 + 4.3 ng/ml to decreasefrom 141 l.Oto 137 l.OmEq/liter(P
(P < 0.01). The peak response was uniformly re- < 0.001) as serum osmolality decreased from 293
corded at 20 mm, and it is this value that is reported 1.7 to 285 + 1.5 (P < 0.001). The serum prolactin
throughout this study. concentration measured at the peak of the water diur-
Table 2. Effect of increased prolactin levels on renal hemodynamics, sodium and water excretiona
Inulin clearance PAH clearance Sodium excretion Free water clearance Urinary osmolality
ml/rniii mi/mm pEq/rnmn mi/nun ,nOsm/kg H20
Subject
No. Control Experimental Control Experimental Control Experimental Control Experimental Control Experimental
128 118 537 497 188 177 11.1 10.4 67 69
6 118 134 791 752 216 272 14.4 16.8 58 56
8 135 134 760 786 190 299 16.1 19.1 49 56
2 98 86 548 451 67 82 9.5 9.8 80 85
7 112 100 55! 503 202 247 13.2 12.9 7! 63
Mean 118.2 114.4 637 597 73 215 12.9 13.8 65 66
SEM 6.4 9.5 57 71 27 39 1.2 1.8 5.3 5.4
Pvalue NS NS NS NS NS
aEach value is the mean of three to four collections. Those in the experimental period are means of collections taken IS to 60 mm after TRH
administration.
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Table 3. Effect of water loading on serum sodium, serum osmolality and serum prolactiri in man
Serum sodium Serum osmolality Serum prolactin
mEq/liter mOsm/kg ng/mI
Control Water load Control Water load Control Water load
6 144 141 290 283 32 34
6 139 134 286 280 30 36
140 134 287 281 27 27
146 143 293 284 25 36
7 138 133 288 277 35 38
7 138 135 292 287 33 36
2 139 136 303 293 IS 20
2 143 138 302 290 26 21
8 142 139 292 285 35 39
9 140 138 297 292 25 20
10 137 134 295 287 23 22
Mean 141 137 293 285 28 30
SEM 1.0 1.0 1.7 1.5 1.8 2.4
Pvalue <0.00! <0.00! N5
esis (90 to 120 mm after the beginning of the water prolactin concentrations almost doubled as the mean
load ) was not significantly altered from control, 28 increased from 27.7 + 1.9 to 53.5 + 3.5 ng/ml (P <
1.8 to 30 2.4 ng/ml. 0.001).
Serum hypertonicity was achieved by the infusion
of 5% NaCI in six subjects undergoing a water diur- Discussion
esis (Table 4). The infusion was associated with an
increase in serum sodium from 137 1.4 to 145 + 1.6 Considerable evidence has accumulated to suggest
mEq/liter (P <0.001) as serum osmolality rose from that the anterior pituitary hormone prolactin plays a
287 + 1.8 to 298 1.4 (P < 0.001). Each subject role in the adaptation of some fish to a fresh water
responded, as expected with a marked antidiuresis, as environment by altering the handling of sodium and
mean urinary osmolality rose from 62 5.9 to 480 water in these animals [1]. An effect of the hormone
48 (P < 0.001). These marked changes in serum on the mammalian kidney was demonstrated by
tonicity and renal water excretion were associated Lockett and Nail who showed that sheep prolactin
with no consistent alteration in serum prolactin con- alters renal hemodynamics and water excretion in the
centration as the mean remained essentially un- cat and the rat [3, 4]. The administration of prolactin
changed at 28 ng/ml. The levels of the hormone at to the rat with congenital diabetes insipidus is also
one and two hours after initiation of the hypertonic associated with an antidiuresis, suggesting a vaso-
NaCI infusion were very similar, and the values at pressin-independent mechanism [5]. However, in this
two hours are shown in the table for all indexes, latter study the increase in urinary osmolality was
Furthermore, the hypertonicity and volume expan- modest and the failure of the urine to attain even the
sion neither blunted nor enhanced the subject's re- level of serum osmolality places considerable doubt
sponse to TRH as shown in Table I, right panel. As on the ability of prolactin to significantly increase the
was the case in the previous groups, here too baseline water permeability of the collecting duct epithelium
Table 4. Effect of hypertonic NaC! administration on serum sodium, serum osmolality, urinary osmolality and serum prolactin in man
Serum sodium Serum osmolality Urinary osniolality Serum prolactin
mEq/Ii!er mOsm/kg H20 rnOsm/kg H20 ng/m/
Hypertonic Hypertonic Hypertonic HypertonicControl saline Control saline Control saline Control saline
143 149 290 299 58 415 36 26
2 138 150 284 30! 77 651 20 30
6 134 140 280 292 5! 412 36 34
7 135 144 287 297 45 372 36 30
9 138 143 292 301 6! 422 20 25
10 36 141 287 297 82 607 22 2!
Mean 137 145 287 298 62 480 28 28
SEM 1.4 1.6 1.8 1.4 5.9 48 3.4 1.9
Pvalue <0.001 <0.00! <0.00! NS
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and thus suggests a different mechanism for the ob-
served antidiuresis.
In contrast to a number of other hormones [15],
the effect of prolactin on water excretion in man has
received only scant attention. Since prolactin prepa-
rations are frequently contaminated with antidiuretic
hormone (Cronin R, Anderson R: unpublished ob-
servation), in the present study we chose rather to
increase the levels of endogenous prolactin by the i.v.
injection of TRH. Although this tripeptide itself
could conceivably alter systemic hemodynamics or
cause other hormonal changes that could alter so-
dium and water excretion, no such effects have so far
been described in vivo. The increase in endogenous
prolactin concentration had no effect whatsoever on
the renal excretion of water. The clearance of PAH
decreased in four of the five subjects studied, but in
view of the variability in this determination, this
change was not statistically significant. A decrease in
renal blood flow, however, would in itself tend to
decrease urine flow and free water clearance and thus
would have tended to potentiate rather than obscure
an antidiuretic effect of prolactin. In spite of the
tendency of the clearance of PAH to decrease, the
excretion of sodium rose slightly in four of the sub-
jects, an increase that again did not reach statistical
significance and that could hardly have obscured an
antidiuretic response. Our results failing to show an
effect of increased prolactin concentrations on water
excretion and, if anything, a small tendency to in-
crease sodium excretion is thus in conflict with the
findings of Horrobin et al [6], who reported a de-
crease in urine flow following the i.m. administration
of 8 mg of sheep prolactin. It is unclear from their
study, however, whether the decrease in urine flow
was due to a decrease in free water clearance or
primarily a consequence of the decreased solute clear-
ance that must have occured as sodium and potas-
sium excretion also declined. This latter effect on
cation excretion could have been due to the growth
hormone, which the authors acknowledge as a con-
taminant, since growth hormone has been noted to
have sodium-retaining properties itself [16]. Al-
though the concentrations of TSH and thyroid hor-
mone must also have increased following TRH ad-
ministration, it seems most unlikely that these would
entirely obscure or antagonize a possible antidiuretic
effect of prolactin. In fact, the observed effect of TSH
on salt and water transport in the toad bladder [17] if
applicable in vivo at the levels attained in this study
should have itself caused an antidiuresis. Since the
concentrations of prolactin reached in our study—.
although clearly above the normal range—are not
extremely high, we cannot exclude the possibility that
much higher levels of the hormone as have been
measured in patients with pituitary tumors [18] or
more chronic stimulation with the hormone may af-
fect renal water handling by either proximal or distal
tubular mechanisms. This could explain the results in
the above study [6] in which, even assuming a very
large volume of distribution, very high concentra-
tions of prolactin must have been reached, as well as
the recent preliminary description of an abnormality
in water excretion in patients with hyperprolacti-
nemia [19]. The failure of any of our water diuresing
subjects to respond to an increase in endogenous
prolactin with an antidiuresis allows us to conclude
that in the achieved concentrations the hormone has
no appreciable effect on the water permeability of the
collecting duct nor on fluid reabsorption in the prox-
imal tubule since such changes would also be ex-
pected to change urine flow in the vasopressin-free
state. The results do not exclude the possibility that
the hormone could affect water excretion in the pres-
ence of vasopressin or affect sodium and water move-
ment in the proximal tubule in a different state of
sodium balance.
Were prolactin to play a physiologic role in the
control of water balance in man, it would be expected
that the state of hydration be a determinant of the
hormone's release. Since there is considerable con-
troversy on this issue in the literature, with earlier
studies claiming the existence of an osmoregulation
of the hormone's release [18, 20], but a more recent
one finding no evidence for it [21], we undertook to
measure the concentrations of prolactin in hypotonic
and hypertonic states. Our results reveal that neither
an acute decrease in seruni tonicity as achieved with
an oral water load nor an acute increase in serum
tonicity as achieved with 5% NaCI significantly al-
tered the measured concentrations of prolactin in our
subjects. In fact, the linear correlation coefficient be-
tween simultaneously measured serum sodium and
prolactin was 0.176 and between serum osmolality
and prolactin 0.341, neither of which are significant.
Our results are therefore in disagreement with those
of Buckman et al, who found that water loading
decreased prolactin concentrations [18, 20], Our
sample taken at the height of the water diuresis, 90 to
120 mm after the water load was begun, closely corre-
sponded to the time at which the authors encountered
the lowest prolactin concentrations. The authors also
conclude in the latter study [20] that hypertonicity
causes the release of prolactin. Further scrutiny of
their data reveals that the four subjects who received
hypertonic NaCI over 30 mm attained serum os-
molalities comparable to those achieved in the pres-
ent study. The serum prolactin concentration, how-
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ever, was increased in only two of them by the end of
the infusion period; 20 mm later the prolactin con-
centration had returned to control levels in one of
them but had become elevated in a third subject. In
our study none of the six subjects rendered hyperos-
motic significantly increased their serum prolactin
concentration although they were clearly capable of
so doing as shown by the subsequent response to
TRH. Our results, therefore, are in agreement with
the recent report of Adler et al [21], who likewise
failed to observe changes in serum prolactin concen-
tration in association with alterations in serum tonic-
ity. Taken together, therefore, our data provide no
evidence for an osmoregulation of prolactin release in
man or for an effect of supraphysiologic levels of the
hormone on renal water excretion in the vasopressin-
free state. A role of prolactin, if any, in the control of
fluid balance in states in which its levels rise such as
the postpartum period [22] or sleep [23], in which the
levels of hormone measured are somewhat lower than
those achieved in this study, is at this time speculative
and will require further investigation.
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